AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model
JCI Insight · 10.03.2025 · 10 (5)
DOI: 10.1172/jci.insight.185193 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 10.03.2025. Verfasst von Takao Ukaji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Connexin 26, Gap Junctions, Gene Editing, Hearing Loss. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Mutations in the gap junction β2 ( GJB2 ) gene, which encodes connexin 26, are the leading cause of genetic deafness. These mutations are characterized by the degeneration and fragmentation of gap junctions and gap junction plaques (GJPs) composed of connexin 26. Dominant-negative mutations of GJB2 , such as R75W, cause syndromic hearing loss and palmoplantar keratoderma. We previously reported that the R75W mutation, a single-base substitution where C is replaced by T, causes fragmentation of GJPs. Therefore, an adenine base editor (ABE), which enables A-to-G base conversions, can potentially be useful for the treatment of this genetic disease. Here, we report that an all-in-one adeno-associated virus (AAV) vector, which includes a compact ABE (SaCas9-NNG-ABE8e) with broad targeting range, and a sgRNA targeting the R75W mutation in GJB2 corrected this pathogenic mutation and facilitated the recovery of the gap junction intercellular communication network of GJPs. In a transgenic mouse model with the GJB2 R75W mutation, AAV-mediated base editing also restored the fragmented GJPs to orderly outlines in cochlear supporting cells. Our findings suggest that an ABE-based base-editing strategy could be an optimal treatment for the dominant form of GJB2 -related hearing loss, GJB2 -related skin diseases, and other deafness-related mutations, especially single-base substitutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Juntendo University Faculty of Medicine, Tokyo, Japan.
- Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Ukaji, T., Arai, D., Tsutsumi, H., Nakagawa, R., Matsumoto, F., Ikeda, K., Nureki, O., & Kamiya, K. (2025). AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model. JCI Insight, 10(5). https://doi.org/10.1172/jci.insight.185193
Vancouver
Ukaji T, Arai D, Tsutsumi H, Nakagawa R, Matsumoto F, Ikeda K, et al. AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model. JCI Insight. 2025;10(5). doi:10.1172/jci.insight.185193
BibTeX
@article{Ukaji2025,
author = {Ukaji, Takao and Arai, Daisuke and Tsutsumi, Harumi and Nakagawa, Ryoya and Matsumoto, Fumihiko and Ikeda, Katsuhisa and Nureki, Osamu and Kamiya, Kazusaku},
title = {AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model},
journal = {JCI Insight},
year = {2025},
volume = {10},
number = {5},
doi = {10.1172/jci.insight.185193}
}
EUVIMED